US BANCORP \DE\ - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$2,373
+91.5%
1,447
+500.4%
0.00%
Q1 2024$1,239
-10.3%
2410.0%0.00%
Q4 2023$1,382
+20.0%
2410.0%0.00%
Q3 2023$1,152
+3.9%
241
-7.7%
0.00%
Q2 2023$1,109
-72.7%
261
-65.8%
0.00%
Q1 2023$4,057
-10.0%
764
+6.4%
0.00%
Q4 2022$4,509
-43.6%
718
-0.6%
0.00%
Q3 2022$8,000
+14.3%
722
-41.0%
0.00%
Q2 2022$7,0001,2230.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 544,196$5,741,00019.52%
Elmwood Wealth Management, Inc. 2,364,240$24,943,00012.45%
72 Investment Holdings, LLC 474,067$5,001,0003.96%
PFM Health Sciences, LP 6,000,000$63,300,0002.29%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 257,892$2,716,0000.87%
Avidity Partners Management LP 3,172,600$33,471,0000.68%
Green Alpha Advisors, LLC 69,376$732,0000.62%
Rokos Capital Management LLP 1,907,509$20,811,0000.62%
Nelson Capital Management, LLC 85,020$897,0000.26%
Tekla Capital Management LLC 567,147$5,983,0000.24%
View complete list of CARIBOU BIOSCIENCES INC shareholders